# Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

> **NCT04804306** · — · COMPLETED · sponsor: **Beckman Coulter, Inc.** · enrollment: 198 (actual)

## Conditions studied

- Sepsis
- Adult Disease
- Emergency Department
- Severe Sepsis

## Interventions

- **DEVICE:** Diagnostic Test: CBC-DIFF Monocyte Volume Width Distribution (MDW)

## Key facts

- **NCT ID:** NCT04804306
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-05
- **Primary completion:** 2022-06-06
- **Final completion:** 2022-06-06
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2022-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804306, "Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04804306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*